Linoleic acid induces interleukin-8 production by Crohn's human intestinal smooth muscle cells via arachidonic acid metabolites

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 286, Issue 4 49-4, 2004, Pages

  Alzoghaibi, Mohammad A ^a   Walsh, Scott W ^a   Willey, Amy ^a   Yager, Dorne R ^a   Fowler III, Alpha A ^b   Graham, Martin F ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Leukotriene B4; NF B; Prostaglandin E2; Thromboxane

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LEUKOTRIENE B4; LINOLEIC ACID; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; THROMBOXANE B2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; FATTY ACID METABOLISM; HUMAN; HUMAN TISSUE; INTESTINE MUSCLE; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER;

EID: 1642398329     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00189.2003     Document Type: Article

References (51)

1. Alzoghaibi MA, Walsh SW, Willey A, Fowler AA 3rd, and Graham MF. Linoleic acid, but not oleic acid, upregulates the production of interleukin-8 by human intestinal smooth muscle cells isolated from patients with Crohn's disease. Clin Nutr. 22: 529-535, 2003.
2. Aoki Y, Qiu D, Zhao GH, and Kao PN. Leukotriene B4 mediates histamine induction of NF-κB and IL-8 in human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 274: L1030-L1039, 1998.
3. Baldwin AS Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 14: 649-683, 1996.
4. Barnes PJ and Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071, 1997.
5. Brandt E, Colombel JF, Ectors N, Gambiez L, Emilie D, Geboes K, Capron M, and Desreumaux P. Enhanced production of IL-8 in chronic but not in early ileal lesions of Crohn's disease (CD). Clin Exp Immunol 122: 180-185, 2000.
6. Breese EJ, Michie CA, Nicholls SW, Murch SH, Williams CB, Domizio P, Walker-Smith JA, and MacDonald TT. Tumor necrosis factor α-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 106: 1455-1466, 1994.
7. Buhner S, Nagel E, Korber J, Vogelsang H, Linn T, and Pichlmayr R. Ileal and colonic fatty acid profiles in patients with active Crohn's disease. Gut 35: 1424-1428, 1994.
8. Casini-Raggi V, Kam L, Chong YJ, Fiocchi C, Pizarro TT, and Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 154: 2434-2440, 1995.
9. Daig R, Andus T, Aschenbrenner E, Falk W, Scholmerich J, and Gross V. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 38: 216-222, 1996.
10. Esteve-Comas M, Nunez MC, Fernandez-Banares F, Abad-Lacruz A, Gil A, Cabre E, Gonzalez-Huix F, Bertran X, and Gassull MA. Abnormal plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease. Gut 34: 1370-1373, 1993.
11. Esteve-Comas M, Ramirez M, Fernandez-Banares F, Abad-Lacruz A, Gil A, Cabre E, Gonzalez-Huix F, Moreno J, Humbert P, Guilera M, Boix J, and Gassull MA. Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease. Gut 33: 1365-1369, 1992.
12. Fowler AA 3rd, Fisher BJ, Sweeney LB, Wallace TJ, Natarajan R, Ghosh SS, and Ghosh S. Nitric oxide regulates interleukin-8 gene expression in activated endothelium by inhibiting NF-κB binding to DNA: effects on endothelial function. Biochem Cell Biol 77: 201-208, 1999.
13. Graham MF, Diegelmann RF, Elson CO, Bitar KN, and Ehrlich HP. Isolation and culture of human intestinal smooth muscle cells. Proc Soc Exp Biol Med 176: 503-507, 1984.
14. Hawkey CJ, Karmeli F, and Rachmilewitz D. Imbalance of prostacyclin and thromboxane synthesis in Crohn's disease. Gut 24: 881-885, 1983.
15. Hommes DW, Meenan J, de Haas M, ten Kate FJ, von dem Borne AE, Tytgat GN, and van Deventer SJ. Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammation. Gut 38: 564-567, 1996.
16. Ina K, Kusugami K, Yamaguchi T, Imada A, Hosokawa T, Ohsuga M, Shinoda M, Ando T, Ito K, and Yokoyama Y. Mucosal interleukin-8 is involved in neutrophil migration and binding to extracellular matrix in inflammatory bowel disease. Am J Gastroenterol 92: 1342-1346, 1997.
17. Ishizuka T, Kawakami M, Hidaka T, Matsuki Y, Takamizawa M, Suzuki K, Kurita A, and Nakamura H. Stimulation with thromboxane A2 (TXA2) receptor agonist enhances ICAM-1, VCAM-1 or ELAM-1 expression by human vascular endothelial cells. Clin Exp Immunol 112: 464-470, 1998.
18. Jentzsch AM, Bachmann H, Furst P, and Biesalski HK. Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 20: 251-256, 1996.
19. Kukreja RC, Kontos HA, Hess MI, and Ellis EF. PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH. Circ Res 59: 612-619, 1986.
20. Lauritsen K, Laursen LS, Bukhave K, and Rask-Madsen J. In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis. Gastroenterology 95: 11-17, 1988.
21. Ligumsky M, Simon PL, Karmeli F, and Rachmilewitz D. Role of interleukin I in inflammatory bowel disease-enhanced production during active disease. Gut 31: 686-689, 1990.
22. Lobos EA, Sharon P, and Stenson WF. Chemotactic activity in inflammatory bowel disease. Role of leukotriene B4. Dig Dis Sci 32: 1380-1388, 1987.
23. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338: 436-445, 1998.
24. Mahida YR, Wu K, and Jewell DP. Enhanced production of interleukin 1β by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut 30: 835-838, 1989.
25. Mazzucchelli L, Hauser C, Zgraggen K, Wagner H, Hess M, Laissue JA, and Mueller C. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol 144: 997-1007, 1994.
26. Minami T, Tojo H, Shinomura Y, Matsuzawa Y, and Okamoto M. Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis. Gut 35: 1593-1598, 1994.
27. Minami T, Tojo H, Shinomura Y, Tarui S, and Okamoto M. Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis. Gut 33: 914-921, 1992.
28. Mitsuyama K, Toyonaga A, Sasaki E, Watanabe K, Tateishi H, Nishiyama T, Saiki T, Ikeda H, Tsuruta O, and Tanikawa K. IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Clin Exp Immunol 96: 432-436, 1994.
29. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
30. Nakamura M, Saito H, Kasanuki J, Tamura Y, and Yoshida S. Cytokine production in patients with inflammatory bowel disease. Gut 33: 933-937, 1992.
31. Natarajan R, Ghosh S, Fisher BJ, Diegelmann RF, Willey A, Walsh S, Graham MF, and Fowler AA 3rd. Redox imbalance in Crohn's disease intestinal smooth muscle cells causes NF-κB-mediated spontaneous interleukin-8 secretion. J Interferon Cytokine Res 21: 349-359, 2001.
32. Neurath MF, Fuss I, Schurmann G, Pettersson S, Arnold K, Muller-Lobeck H, Strober W, Herfarth C, and Buschenfelde KH. Cytokine gene transcription by NF-κ B family members in patients with inflammatory bowel disease. Ann NY Acad Sci 859: 149-159, 1998.
33. Olaison G, Leandersson P, Sjodahl R, and Tagesson C. Increase in permeability and phospholipase A2 activity of colonic mucosa in Crohn's colitis. Digestion 43: 228-233, 1989.
34. Olaison G, Sjodahl R, and Tagesson C. Increased phospholipase A2 activity of Ileal mucosa in Crohn's disease. Digestion 41: 136-141, 1988.
35. Pacheco S, Hillier K, and Smith C. Increased arachidonic acid levels in phospholipids of human colonic mucosa in inflammatory bowel disease. Clin Sci (Lond) 73: 361-364, 1987.
36. Pereira SP, Cassell TB, Engelman JL, Sladen GE, Murphy GM, and Dowling RH. Plasma arachidonic acid-rich phospholipids in Crohn's disease: response to treatment. Clin Sci (Lond) 91: 509-512, 1996.
37. Poligone B and Baldwin AS. Positive and negative regulation of NF-κB by COX-2: roles of different prostaglandins. J Biol Chem 276: 38658-38664, 2001.
38. Pullman WE, Sullivan PJ, Barratt PJ, Lising J, Booth JA, and Doe WF. Assessment of inflammatory bowel disease activity by technetium 99m phagocyte scanning. Gastroenterology 95: 989-996, 1988.
39. Reimund JM, Wittersheim C, Dumont S, Muller CD, Baumann R, Poindron P, and Duclos B. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. J Clin Immunol 16: 144-150, 1996.
40. Reimund JM, Wittersheim C, Dumont S, Muller CD, Kenney JS, Baumann R, Poindron P, and Duclos B. Increased production of tumour necrosis factor-α interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut 39: 684-689, 1996.
41. Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, and Raedler A. Enhanced secretion of tumour necrosis factor-α, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 94: 174-181, 1993.
42. Saverymuttu SH, Peers AM, Lavender JP, Chadwick VS, and Hodgson HJ. In vivo assessment of granulocyte migration to diseased bowel in Crohn's disease. Gut 26: 378-383, 1985.
43. Schreck R, Rieber P, and Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κ B transcription factor and HIV-1. EMBO J 10: 2247-2258, 1991.
44. Sen CK and Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 10: 709-720, 1996.
45. Sharon P and Stenson WF. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 86: 453-460, 1984.
46. Singer II, Kawka DW, Schloemann S, Tessner T, Riehl T, and Stenson WF. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115: 297-306, 1998.
47. Spector AA and Yorek MA. Membrane lipid composition and cellular function. J Lipid Res 26: 1015-1035, 1985.
48. Van Dullemen HM, van Deventer SJ, Hommes DW, Bijl HA, Jansen J, Tytgat GN, and Woody J. Treatment of Crohn's disease with antitumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109: 129-135, 1995.
49. Walsh SW, Vaughan JE, Wang Y, and Roberts LJ II. Placental isoprostane is significantly increased in preeclampsia. FASEB J 14: 1289-1296, 2000.
50. Winyard PG and Blake DR. Antioxidants, redox-regulated transcription factors, and inflammation. Adv Pharmacol 38: 403-421, 1997.
51. Yamada T and Grisham MB. Role of neutrophil-derived oxidants in the pathogenesis of intestinal inflammation. Klin Wochenschr 69: 988-994, 1991.